Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases
Authors:
- Silvia Ruiz-GaspàSRSilvia Ruiz-Gaspà
- Nuria GuañabensNGNuria Guañabens
- Susana Jurado GonzálezSGSusana Jurado González
- Marta DubreuilMDMarta Dubreuil
- Andres CombaliaACAndres Combalia
- Pilar PerisPPPilar Peris
- Ana MonegalAMAna Monegal
- Albert ParésAPAlbert Parés
Preprint
Abstract
Osteoporosis in advanced cholestatic and end-stage liver disease is related to low bone formation. Previous studies have demonstrated the deleterious consequences of lithocholic acid (LCA) and bilirubin on osteoblastic cells. These effects are partially or completely neutralized by ursodeoxycholic acid (UDCA). We have assessed the differential gene expression of osteoblastic cells under different culture conditions. The experiments were performed in human osteosarcoma cells (Saos-2) cultured with LCA 10 μM), bilirubin (50 μM) or UDCA (10 and 100 μM) at 2 and 24 hours. Expression of 87 genes related to bone metabolism and other signalling pathways were assessed by TaqMan micro fluidic cards. Several genes were up-regulated by LCA, most of them pro-apoptotic ( BAX , BCL10 , BCL2L13 , BCL2L14 ), but also MGP (matrix Gla protein), B GLAP (osteocalcin), SPP1 (osteopontin) and CYP24A1 , and down-regulated bone morphogenic protein genes ( BMP3 and BMP4 ) and DKK1 (Dickkopf-related protein 1). Parallel effects were observed with bilirubin, which up-regulated apoptotic genes and CSF2 (colony-stimulating factor 2) and down-regulated antiapoptotic genes ( BCL2 and BCL2L1) , BMP3 , BMP4 and RUNX2. UDCA 100 μM had specific consequences since differential expression was observed, up-regulating BMP2 , BMP4 , BMP7 , CALCR (calcitonin receptor), SPOCK3 (osteonectin), BGLAP (osteocalcin) and SPP1 (osteopontin), and down-regulating pro-apoptotic genes. Furthermore, most of the differential expression changes induced by both LCA and bilirubin were partially or completely neutralized by UDCA. Conclusion : Our observations reveal novel target genes, whose regulation by retained substances of cholestasis may provide additional insights into the pathogenesis of osteoporosis in cholestatic and end-stage liver diseases.Keywords
All Related Versions
- Published version: Gene, 725, 144167.
This publication has 37 references indexed in Scilit:
- Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseasesHepatology, 2010
- Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availabilityCytokine, 2010
- Genetic and Transcriptional Control of Bone FormationOral and Maxillofacial Surgery Clinics of North America, 2010
- Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor CellsJournal of Biological Chemistry, 2009
- Genetic Analysis of the Roles of BMP2, BMP4, and BMP7 in Limb Patterning and SkeletogenesisPLOS Genetics, 2006
- Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosisJournal of Hepatology, 2005
- BMP signaling in skeletal developmentBiochemical and Biophysical Research Communications, 2005
- Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteinsOncogene, 2004
- Short‐Term BMP‐2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem CellsStem Cells, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001